BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 13936572)

  • 1. Further evidence for a role of the renin-angiotensin system in regulation of aldosterone secretion.
    MULROW PJ; GANONG WF; BORYCZKA A
    Proc Soc Exp Biol Med; 1963 Jan; 112():7-10. PubMed ID: 13936572
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute effects of the calcium antagonist, nifedipine, on blood pressure, pulse rate, and the renin-angiotensin-aldosterone system in patients with essential hypertension.
    Hiramatsu K; Yamagishi F; Kubota T; Yamada T
    Am Heart J; 1982 Dec; 104(6):1346-50. PubMed ID: 6293295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The state of the renin-angiotensin-aldosterone system in various clinical forms of hypertension in aging.
    Chebotarev DF; Korkushko OV; Asinova MI; Ershova GS
    Arch Gerontol Geriatr; 1985 Apr; 4(1):21-8. PubMed ID: 3890783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [REGULATION OF ALDOSTERONE SECRETION. ROLE OF THE KIDNEY AND THE RENIN-ANGIOTENSIN SYSTEM (HYPERTENSIN)].
    MILLS LF; HAMILTON PM
    Annee Endocrinol; 1963; 15():21-6. PubMed ID: 14333522
    [No Abstract]   [Full Text] [Related]  

  • 5. [Renin-aldosterone system in secretion of cortisol in patients with arterial hypertension in European North].
    Iakovlev VA; Sokol LIu; Karlov VA
    Klin Med (Mosk); 1998; 76(1):35-7. PubMed ID: 9532913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute inhibition of the renin-angiotensin system: interest and limits to detect surgically curable hypertension.
    Pagny JY; Thibonnier M; Corvol P; Menard J
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S82-5. PubMed ID: 2412019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of the ovarian/endometrial renin-angiotensin-aldosterone system.
    Hassan E; Creatsas G; Mastorakos G; Michalas S
    Ann N Y Acad Sci; 2000; 900():107-18. PubMed ID: 10818397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure and the renin--angiotensin--aldosterone system.
    Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():261s-263s. PubMed ID: 7032815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of evidence for the interaction between renin-angiotensin-aldosterone system and endothelin in vivo.
    Widimský J; Dvoráková J; Hladovec J; Kopecká J
    Physiol Res; 1996; 45(3):241-3. PubMed ID: 9200216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
    Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M
    Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Historical perspectives on the renin-angiotensin-aldosterone system and angiotensin blockade.
    Davis JO; Freeman RH
    Am J Cardiol; 1982 Apr; 49(6):1385-9. PubMed ID: 6280472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is there a relation between the renin-angiotensin-aldosterone system and vasopressin secretion in essential hypertension?].
    Wiecek A; Kokot F
    Z Gesamte Inn Med; 1984 Dec; 39(23):578-82. PubMed ID: 6396982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The importance of studying the renin-angiotensin-aldosterone system in essential arterial hypertension in clinical practice. Activity of the renin-angiotensin-aldosterone system during treatment of hypertension with ACE-inhibitors and beta blockers].
    Hrnciar J; Hrnciarová M; Lepej J; Okálová D; Kreze A; Chamulová M
    Vnitr Lek; 1994 Sep; 40(9):557-62. PubMed ID: 7975357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ON THE IMPORTANCE OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN THE PATHOGENESIS OF RENAL HYPERTENSION].
    BOGATZKI M
    Med Klin; 1964 Jun; 59():1046-8. PubMed ID: 14243291
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood pressure in relation to the renin-angiotensin-aldosterone system.
    Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
    Acta Med Scand; 1982; 211(5):351-60. PubMed ID: 7051760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin-aldosterone system and hypertension in primary hyperparathyroidism.
    Ganguly A; Weinberger MH; Passmore JM; Caras JA; Khairi RM; Grim CE; Edmonson J; Johnston CC
    Metabolism; 1982 Jun; 31(6):595-600. PubMed ID: 7043184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
    Athyros VG; Mikhailidis DP; Kakafika AI; Tziomalos K; Karagiannis A
    Expert Opin Pharmacother; 2007 Apr; 8(5):529-35. PubMed ID: 17376010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and depressed symptomatology: a cluster related to the activation of the renin-angiotensin-aldosterone system (RAAS). Findings from population based KORA F4 study.
    Häfner S; Baumert J; Emeny RT; Lacruz ME; Bidlingmaier M; Reincke M; Ladwig KH
    Psychoneuroendocrinology; 2013 Oct; 38(10):2065-74. PubMed ID: 23608138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renin-angiotensin-aldosterone system in hypertension patients who have had a cerebral stroke].
    Fedirko MI; Ershova GS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1321-3. PubMed ID: 3321797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The renin-angiotensin-aldosterone system in hypertension of hypothalamic origin].
    Slavnov VN; Markov VV; Oleĭnik VA; Luchitskiĭ EV; Rudichenko VM
    Klin Med (Mosk); 1989 Oct; 67(10):60-4. PubMed ID: 2615308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.